APP and Alzheimer disease: Further analysis revealed that circHDAC9 acts as a “sponge” for miR-138 in vitro, inhibiting the expression of miR-138 and relieving AD-like phenotypes, including abnormal processing of APP, spatial learning/memory decline, and dendritic spine degeneration (Fig. 2).